STIM Neuronetics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: STIM

Price (delayed)

$1.465

Market cap

$101.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.54

Enterprise value

$168.37M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 26

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial ...

Highlights
The revenue has soared by 70% YoY
STIM's EPS has soared by 59% YoY and by 8% from the previous quarter
The company's debt fell by 5% QoQ but it rose by 3.5% YoY
STIM's equity has dropped by 63% year-on-year and by 41% since the previous quarter
Neuronetics's quick ratio has decreased by 36% YoY and by 26% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neuronetics.com
Peers: OBIO OM

Key stats

What are the main financial stats of STIM

STIM stock price

How has the Neuronetics stock price performed over time
Intraday
5.4%
1 week
-4.87%
1 month
-27.48%
1 year
-62.24%
YTD
6.16%
QTD
1.03%

Financial performance

How have Neuronetics's revenue and profit performed over time
Revenue
$151.64M
Gross profit
$72.72M
Operating income
-$29.42M
Net income
-$37.11M
Gross margin
48%
Net margin
-24.5%
The revenue has soared by 70% YoY
The company's operating margin has surged by 55% YoY and by 8% QoQ
The company's net margin has surged by 55% YoY and by 6% QoQ
The gross profit has grown by 28% YoY

Price vs fundamentals

How does STIM's price correlate with its fundamentals

Growth

What is Neuronetics's growth rate over time

Valuation

What is Neuronetics stock price valuation
P/E
N/A
P/B
7.56
P/S
0.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.11
STIM's EPS has soared by 59% YoY and by 8% from the previous quarter
STIM's price to book (P/B) is 118% more than its 5-year quarterly average of 3.3 and 7% more than its last 4 quarters average of 6.7
STIM's equity has dropped by 63% year-on-year and by 41% since the previous quarter
The revenue has soared by 70% YoY
The P/S is 62% below the 5-year quarterly average of 1.7 and 47% below the last 4 quarters average of 1.2

Efficiency

How efficient is Neuronetics business performance
STIM's ROS has soared by 59% YoY and by 9% from the previous quarter
STIM's ROIC is up by 40% YoY and by 3.9% from the previous quarter
The return on assets has increased by 37% year-on-year and by 2.2% since the previous quarter
The ROE has grown by 22% YoY but it has contracted by 19% from the previous quarter

Dividends

What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STIM.

Financial health

How did Neuronetics financials performed over time
The total assets is 16% more than the total liabilities
Neuronetics's quick ratio has decreased by 36% YoY and by 26% from the previous quarter
STIM's current ratio is down by 32% YoY and by 17% from the previous quarter
STIM's debt to equity has soared by 176% YoY and by 59% QoQ
STIM's equity has dropped by 63% year-on-year and by 41% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.